BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19076378)

  • 1. Informed development of drugs acting at family B G protein-coupled receptors.
    Miller LJ
    Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK; Flanagan JU; Watkins HA; Gingell JJ; Hay DL
    Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
    Dong M; Pinon DI; Asmann YW; Miller LJ
    Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
    Miller LJ; Dong M; Harikumar KG; Gao F
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class-B GPCR activation: is ligand helix-capping the key?
    Neumann JM; Couvineau A; Murail S; Lacapère JJ; Jamin N; Laburthe M
    Trends Biochem Sci; 2008 Jul; 33(7):314-9. PubMed ID: 18555686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class B GPCRs: a hidden agonist within?
    Beinborn M
    Mol Pharmacol; 2006 Jul; 70(1):1-4. PubMed ID: 16632645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.
    Hoare SR
    Drug Discov Today; 2005 Mar; 10(6):417-27. PubMed ID: 15808821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.
    Wheatley M; Simms J; Hawtin SR; Wesley VJ; Wootten D; Conner M; Lawson Z; Conner AC; Baker A; Cashmore Y; Kendrick R; Parslow RA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):717-20. PubMed ID: 17635132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of photoaffinity labeling to understand the molecular basis of ligand binding to the secretin receptor.
    Dong M; Miller LJ
    Ann N Y Acad Sci; 2006 Jul; 1070():248-64. PubMed ID: 16888175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
    Sankararamakrishnan R
    Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The orthosteric agonist-binding pocket in the prototypic class B G-protein-coupled secretin receptor.
    Miller LJ; Dong M
    Biochem Soc Trans; 2013 Feb; 41(1):154-8. PubMed ID: 23356276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
    Parthier C; Reedtz-Runge S; Rudolph R; Stubbs MT
    Trends Biochem Sci; 2009 Jun; 34(6):303-10. PubMed ID: 19446460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.